Table 2.
Micellar electrokinetic chromatographic methods for determination of CP.
| Technique | Column (C) | Mobile phase or eluent | Conditions | Matrices | Reference |
|---|---|---|---|---|---|
| MEKC | Uncoated FSC of 50 μm | 6 mM Na2B4O7, 10 mM Na2HPO4, 75 mM SDS pH 9.1 | 257∗∗, V of 15 kV | Human serum and plasma | [50] |
| MEKC | Uncoated FSC of 40.2 cm × 50 μm id | Tris with SDS : MeOH | 214∗∗, V of 15 kV | Plasma and cerebrospinal fluid | [51] |
| MEKC | Uncoated FSC of 31.2 cm (21 cm × 675 mm ID) | 10 mM tris buffer pH 8.0 + 150 mM SDS and 20 mM tris buffer pH 9.0 + 200 mM SDS | 254∗∗, V was 8 kV | Plasma and cerebrospinal fluid | [52] |
| MEKC | Bare FSC of 50 µm, 5 mmol with length 56 cm | Imidazole buffer pH 5.1 | 240∗∗, V of 25 kV | NMP in CP for injection | [53] |
| MEKC | Uncoated FSC length 31.2 cm | Tris buffer + SDS as an electrolyte solution | 214∗∗, V of 15 kV | Commercial injections | [54] |
| MEKC + indirect UV | MEKC [A 50 lm i.d 64.5 cm (56 cm detection length) bare FSC] IC [Gel IC-Cation-SW C (4.6 50 mm, 5 lm) supported by a water's cation GC (4.6·50 mm, 10 lm)] |
MEKC (10 mM creatinine pH 3.8) IC (ACN: 0.01 mM nitric acid) (1 : 100) |
225∗∗ MEKC (V of 30 kV) IC (1∗) |
NMP in CP for injection | [55] |
| CZE | FSC (48.6 cm × 50 µm i.d.) with 40.2 cm as a detection length 40.2 cm) | 15 mm sodium borate buffer pH 9.3 | 215∗∗, V was 20 kV | Pharmaceutical formulations and human plasma |
[56] |
∗ (ml/min); ∗∗ (nm).